chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling hot; Sore left arm; Looked pale; Low grade fever; Severe headache; Joint pain; Felt bad chills; Felt ringing sound in her ears; Very hot sweaty; Felt very thirsty; Black spots in front of her eyes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), TINNITUS (Felt ringing sound in her ears), HYPERHIDROSIS (Very hot sweaty), THIRST (Felt very thirsty) and VISUAL IMPAIRMENT (Black spots in front of her eyes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced TINNITUS (Felt ringing sound in her ears), HYPERHIDROSIS (Very hot sweaty), THIRST (Felt very thirsty), VISUAL IMPAIRMENT (Black spots in front of her eyes) and CHILLS (Felt bad chills). On 30-Dec-2020, the patient experienced PAIN IN EXTREMITY (Sore left arm), PALLOR (Looked pale), PYREXIA (Low grade fever), HEADACHE (Severe headache) and ARTHRALGIA (Joint pain). On an unknown date, the patient experienced FEELING HOT (feeling hot). On 01-Jan-2021, HEADACHE (Severe headache) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore left arm), TINNITUS (Felt ringing sound in her ears), HYPERHIDROSIS (Very hot sweaty), THIRST (Felt very thirsty), VISUAL IMPAIRMENT (Black spots in front of her eyes), PALLOR (Looked pale), CHILLS (Felt bad chills), PYREXIA (Low grade fever) and ARTHRALGIA (Joint pain) had resolved and FEELING HOT (feeling hot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, Body temperature: 99.5 f (abnormal) Low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
HIVES & ITCHING OVER ENTIRE BODY.  STARTED FRIDAY, 10-17-06 @ 11 PM.  CALLED PHYSICIAN ON SUNDAY.  PHYSICIAN DETERMINED THAT IT WAS A REACTION TO THE INFLUENZA VACCINATION.  PATIENT WAS GIVEN A PRESCRIPTION FOR A 10 DAY REGIME OF PREDNISONE.  THE WELTS FELT WARM, BUT THERE WAS NO GENERALIZED FEVER.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Mar2021 as dose 1, single (Lot number: ER8732), in left arm, on 17Apr2021 as dose 2, single (Lot number: EW0169), in left arm and on 14Nov2021 as dose 3 (booster), single (Lot number: FG3527) at the age of 36 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "IBS" (unspecified if ongoing); "known allergies: Lactose" (unspecified if ongoing); "known allergies: scallops" (unspecified if ongoing); "known allergies: cats" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: Positive, notes: COVID 19 Treatment/ testing positive again as well; Negative, notes: I started testing negative again after 5; Positive, notes: I started testing positive again as well. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Addition information: Treatment start date was 16May2022. Treatment stop date was 21May2022. Adverse event- 5 days after completing my Paxlovid I fully relapsed. Symptoms were a little different this time and I was more tired than my first round of COVID symptoms. I started testing positive again as well. Symptoms subsided after 3 days. I started testing negative again after 5.
no adverse effect; The Nurse reports that on 6/13/2019. 1 specified patient received improperlv stored PROQUAD (lot S002924 & expiration 7/28/2020).; This spontaneous report was received from a nurse refers to a 6-year-old patient of unknown gender. The patient's concurrent condition and medical history were unknown. The patient's concomitant therapy included sterile diluent (STERILE DILUENT). On 13-JUN-2019, the patient received improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) of lot # S002924 with expiry date 28-JUL-2020, therapy type: rha (strength, dose, frequency, route of administration unknown) for prophylaxis (product storage error). The measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was reconstituted with properly stored diluent. On an unknown date, the vaccine was exposed to temperature of 6 °Fahrenheit (°F) to 14 °F (10.4 F) for 1 hour and 30 minutes. Previous temperature excursion was on temperature of 6 °F to 14 °F (10.4 F) for 1 hour and 56 minutes and 15 °F to 46 °F (29 F) for 5 hours. The data logger was involved. No adverse effects reported. The outcomes of the events were unknown. No product quality complaint involved.
Immediately after she received H1N1 vaccine, she states her left arm went completely numb for 15-20 min and afterwards became very sore, and started becoming very dizzy and light headed with heart racing. Noted resting heart rate 122. 10/26/09 Medical records received for date 10/22/09. Presenting SX: Pt. is 34wks pregnant with c/o receiving H1N1 vaccine and immed had arm numbness lasting 20min. Then site of vax became sore, pt c/o dizziness. Assessment: increase BP, HR increased.
Pain and swelling of R deltoid area. Erythema and induration surrounding injection site.
20 weeks Pregnant patient got first dose of Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (20 weeks Pregnant patient got first dose of Moderna vaccine) in a 30-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage (Miscarriage at 6 weeks) on 12-Oct-2017, Pregnancy (live full term birth) on 21-Feb-2019 and Alcoholism (1/week). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 27-Oct-2020 and the estimated date of delivery was 03-Aug-2021. On 18-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (20 weeks Pregnant patient got first dose of Moderna vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (20 weeks Pregnant patient got first dose of Moderna vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Dec-2020, Pregnancy test: unknown (Positive) Positive. On an unknown date, Ultrasound scan: unknown (Inconclusive) MONITORING FOR MARGINAL PREVIA.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter.  Patient was positive to pregnancy on 03DEC2021 and no. of fetuses were one and patient reported the complication during the pregnancy was monitoring for marginal previa during ultrasounds.
The 21st, I only felt some fatigue and tiredness as well as the injection site was tender. The following morning, however, was very unpleasing!!! My entire left arm was swollen TWICE its normal size. The injection site was extremely tender to the touch. I could barely use my arm. I had to assist that arm with my other arm. I was extremely lethargic/tired/fatigued. So much that I was in bed 95% of that 24-36 hour time frame; unconscious!!! I was having sporadic "head changes" all day. I was very scared and worried!!! I was unable to perform task at home as well as was unable to work!!!
Patient has redness, swelling, heat at varicella injection site. Does not have SOB, difficulty breathing/reaction is getting worse and has been present for 2-3 days. Referred to MD.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions and concomitant medications were not reported. On 04-JUN-2016 the patient was vaccinated with first dose of RECOMBIVAX HB (route, dose, frequency, lot # not reported). On 25-JUN-2016, the patient was vaccinated with second dose of RECOMBIVAX HB (inappropriate schedule of drug administration). The patient did not experience adverse event. Additional information has been requested.
Erythema and tenderness (at 8 cm x 7 cm) was present for 3-4 days at the site of injection. On Day 5, severe fatigue began and I stayed in bed most of the day (holiday) and this fatigue waxed and waned through Day 11, which was the most severe episode of it. I experienced odd myalgias (thighs aching), headaches, and a decreased ability to concentrate Days 5-11. On Day 11, I woke up after 10 hours of sleep with a headache and slight vertigo and spent most of that day in bed, resting. Today is Day 12, and I feel significantly better. I had ZOSTAVAX at age 60, and had no side effects, and having read that no research has been done on people who have ZOSTAVAX and SHINGRIX less than 5 years apart, I wonder if the short time between the two might put one at risk for more side effects. I am a nurse practitioner and very much an advocate for vaccines. I had a flu vaccine a week before the SHINGRIX.
a large heart murmur; Numbness in hands, arms, legs, feet; Extreme sensitivity when anything touches these limbs; Unable to walk, stand or balance; Unable to walk, stand or balance; Unable to walk, stand or balance; COVID Test: Nasal Swab / Result: Positive; COVID Test: Nasal Swab / Result: Positive; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received BNT162b2, administered in arm left, administration date 18Sep2021 (Batch/Lot number: unknown) at the age of 52 years as dose 1, single for COVID-19 immunisation. The patient had no relevant medical history. There were no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. There were no other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The following information was reported: CARDIAC MURMUR (hospitalization, disability) with onset 27Sep2021, outcome "not recovered", described as "a large heart murmur"; HYPOAESTHESIA (hospitalization, disability) with onset 27Sep2021, outcome "not recovered", described as "Numbness in hands, arms, legs, feet"; HYPERAESTHESIA (hospitalization, disability) with onset 27Sep2021, outcome "not recovered", described as "Extreme sensitivity when anything touches these limbs"; GAIT INABILITY (hospitalization, disability), DYSSTASIA (hospitalization, disability), BALANCE DISORDER (hospitalization, disability) all with onset 27Sep2021, outcome "not recovered" and all described as "Unable to walk, stand or balance"; COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID Test: Nasal Swab / Result: Positive". Clinical course: Numbness in hands, arms, legs, feet. Extreme sensitivity when anything touches these limbs, unable to walk, stand or balance. Also gave the patient a large heart murmur. The patient was hospitalized for cardiac murmur, hypoaesthesia, hyperaesthesia, gait inability, dysstasia, balance disorder (hospitalization duration: 2 days). The events "a large heart murmur", "numbness in hands, arms, legs, feet", "extreme sensitivity when anything touches these limbs", "unable to walk, stand or balance", "unable to walk, stand or balance" and "unable to walk, stand or balance" were evaluated at the physician office visit and emergency room visit. The patient underwent COVID test: Nasal Swab (unspecified date) with result positive, notes: Post vaccination. Therapeutic measures were not taken as a result of cardiac murmur, hypoaesthesia, hyperaesthesia, gait inability, dysstasia, balance disorder.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I got the vaccine on my left arm, and a lump appeared on my left arm pit and it hurt.  My arm pit got swollen, but it's slowly going away.  This was for the 3rd dose of pfizer for the other 2 I didn't have any reaction.
Was informed at the time the client was to be seen for booster dose of COVID vaccine that he had recently passed away. Unable to contact family for more Information.
Patient reported that she will not be receiving 2nd dose of SHINGRIX because after 1st dose given on 9/10/18 she developed a break out of herpes zoster in her mouth and her inner lip, she had to take valacyclovir for her breakout. She normally takes valacyclovir for PRN breakouts, but this one was more severe than normal.
Pt recvd vax 29APR93 & devel rash & a fever 103;
BUD of Moderna Vial (in Fridge) was 11/5/22, administered on 11/7/22
PATIENT EXPERIENCED VERTIGO AT NIGHT ON THE THIRD DAY. AFTER RECEIVING THE VACCINE. ON 8/5, PATIENT RECOVERED. AND NORMAL.
As the patient was sitting out in the lobby, within 11 minutes of receiving her booster (#3 dose) she began having a seizure that lasted around 2 to 3 minutes.  After the seizure stopped, we noticed the patients' tongue became swollen and she wasn't talking clearly. She wanted water, after she took a drink she began to throw-up.  We called 991 to have EMS take her to the ER.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 14Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 14Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 32 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "obesity" (unspecified if ongoing). Concomitant medication(s) included: DAYQUIL AND NYQUIL SEVERE+  VAPOCOOL COLD AND FLU, start date: 20Jun2022, stop date: 22Jun2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 30Jun2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Jun2022) Negative; (29Jun2022) Negative; (30Jun2022) Positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
VERY RED NODULE-SIZE GOLF BALL RIGHT ARM.  10/27/08 STILL RED AND SORE TODAY.
10 days after the vaccination my vision decreased and it was in the morning till 4 hours, my weakness was so severe I was so afraid of not being able to walk again, My balance and my walking was affected.
Upon waking up the morning after vaccination (about 15 hours after), I felt tired and the arm I recieved the injection in ached. The tired feeling and ache in my arm continued throughout the entire day. The following day (03/11/2021) I woke up (around 5:00am) with body aches and a headache that intensified until about 2:00pm, when body aches and headache subsided quickly. I felt tired the rest of the day.   03/12/2021 while not diagnosed by a doctor, I also recieved a penile yeast infection after having intercourse with my girlfriend. It cleared up within a week using a 2% miconazole nitrate cream. Not sure if this is related to the vaccine, but a similar thing happened after my second dose (will be reported in an additional report).
Red swollen and hot to the touch reaction. No pain or fever reported. Treatment is to use warm compresses if needed and to keep an eye on it if it is to get larger. Patient is to return to clinic if symptoms worsen.
I am reporting a vaccination error.  My wife took my 2 month old baby to doctor's office for his first round of routine vaccinations. Afterward, the nurse came into the room, and stated that she gave him the wrong vaccine! She gave him a vaccine that was meant for a 12 month olds body. UNACCEPTABLE! She stated that the vials were next to each other and similar in appearance and she must have grabbed the wrong one. She then proceeded to give him the correct vaccine when my wife told her NO, and asked to speak to the doctor. Not only was my newborn son injected with an incorrect vaccine and dosage, he is now behind on the vaccination schedule because they have to be given a certain time apart. Furthermore, my son will need to make an unnecessary separate appointment for the correct vaccination, thus exposing him to more things (Coronavirus). Completely unacceptable! Also, I am still monitoring my newborn for any potential side effects from this poor nurses error.
One month after receiving my COVID-19 booster, I came down with shingles on my face/ear (for the second time, same location) and had a Bartholin cyst (for the second time, same location) simultaneously as happened 6 months ago. The same issues occurred two months after my second dose (Moderna). I had shingles and a Bartholin cyst. The shingles brought Ramsay Hunt syndrome (Bells Palsy on the same side as the shingles that lasted 1 month) and post-herpetic neuralgia (still feeling symptoms to date).
Brain-spasms/Brain-zapps; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (003110). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "low-self esteem" (unspecified if ongoing), notes: mental condition called low-self esteem. The patient's concomitant medications were not reported. The following information was reported: ELECTRIC SHOCK SENSATION (non-serious), outcome "unknown", described as "Brain-spasms/Brain-zapps".  The lot number for bnt162b2 was not provided and will be requested during follow up.
patient states that he found that people were not getting the second dose within 6 weeks after the first dose; No adverse event; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient states that he found that people were not getting the second dose within 6 weeks after the first dose) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19.     On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient states that he found that people were not getting the second dose within 6 weeks after the first dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient states that he found that people were not getting the second dose within 6 weeks after the first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient states that he found that people were not getting the second dose within 6 weeks after the first dose).    No concomitant medications were reported. No treatment medications were reported.
HPV#1 was given and pt c/o a warm feeling, she started to stare, pupils dilated and color went pale. Pt was quickly helped to a supine position and was responsive and did not have a loss of consciousness due to quick action
Left deltoid soreness for 2 days, follow by lymph node swelling behind left chest wall for 2 days. Mild rash on chest with itching followed for 2 days, now all resolved.
Day following vaccine, throbbing pain developed on opposite arm/shoulder, leading to decreased/limited range of motion.
Received her 2nd dose of the Moderna vaccine with 0.4ML dose; A spontaneous report was received from a nurse concerning a 53-year-old female patient, who received Moderna's covid-19 vaccine (mRNA-1273) with 0.4 ml dose (Accidental underdose).  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 08 FEB 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number: 007M20A, expiry 25th FEB) via unknown route for prophylaxis of COVID-19 infection.  On 08 FEB 2021, the patient received mRNA-1273 vaccine from an health care professional, who administered 0.4 ml lower dose of vaccine. Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event(s), therefore action taken with the drug in response to the event is not applicable.  The outcome of the event received second dose of the Moderna vaccine with 0.4ML dose was recovered.; Reporter's Comments: This report refers to a case of accidental underdose for mRNA-1273 (lot # 007M20A) with no associated AEs reported.
Brought in by parent to Peds ER on 2/23/01 complaining of rash at injection site. Received shot on Tuesday.
Red, swollen, itchy, 3 inches long, 1 1/2 - 2 in below injection site.
22Aug89 pt vax w/ 2nd hepta B; exp transitory arthralgia involving wrists, elbows, and left ankle + persistent aching of hands.  29Jan90 pt vax 3rd hepta B;  Mar90 exp worsening of sx. pt tx w/ ibuprofin.  26Apr90 post vax titer was 220.6RU
No additional adverse events reported; a dose of Improperly Stored VARIVAX has been administered to a patient; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported.   On 21-JAN-2022, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml (route not reported; lot #U020244, expiration date 28-JUN-2023) for prophylaxis (product storage error).   The administered dose of the vaccine experienced a temperature excursion in the range 6 Fahrenheit degrees up to 14 Fahrenheit degrees (13.8 Fahrenheit degrees) for 1 hour 45 minutes and 0 seconds, and in the range 14 Fahrenheit degrees up to 46 Fahrenheit degrees (14.4 Fahrenheit degrees) for 0 hours 25 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported.
Pt received flu vaccine and then reported feeling dizzy at check out in front store to store associate. Pt was given a seat to sit in, was offered a call to 911 but denied it, had a cup of water and then left with husband. RPh called pt at home and she stated she was feeling fine.
Extreme swelling of lymph nodes and parotid glands in the neck and jaw area extending into the lower face and below the ears.  Also swelling in the upper center chest directly below the neck.  Scratchy throat, itchy eyes, dry mouth and some trouble swallowing in the morning when awakening.